Ron Martell, President and CEO at Jasper Therapeutics, Inc. (JSPR), bought 41,000 shares at $2.43 ($100K) on 2025-09-22, disclosed to the SEC on 2025-09-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| IMCL | SELL | 2006-04-14 | $184K | — | Filing → |